Heron Therapeutics Inc. (HRTX)
HRTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3906
-6.01% on the day
Market cap
$74.2M
Micro cap
Revenue · 2025
$154.9M
No prior year to compare
Net income · 2025
-$20.0M
-12.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/818033/000119312526073515/0001193125-26-073515-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | HRTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000818033 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $154.9M |
| Net income | -$20.0M |
| Operating income | -$2.5M |
| Net margin | -12.9% |
| Operating margin | -1.6% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $28.6M |
| Total assets | $255.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-09-09 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
| CTOR | Citius Oncology Inc. | $0.7920 | -2.54% | $73.6M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
| ACRV | Acrivon Therapeutics Inc. | $1.75 | -7.89% | $75.0M |
| INCR | Intercure Ltd. | $5.03 | +1.62% | $75.5M |
| MAIA | MAIA Biotechnology Inc. | $1.16 | -1.70% | $71.6M |
| NTHI | NeOnc Technologies Holdings Inc. | $2.60 | -4.95% | $77.2M |
| RFL | Rafael Holdings Inc. | $1.49 | -1.97% | $77.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier